Astralis As Stock EBITDA

ASGRFDelisted Stock  USD 0.24  0.00  0.00%   
Astralis AS fundamentals help investors to digest information that contributes to Astralis' financial success or failures. It also enables traders to predict the movement of Astralis Pink Sheet. The fundamental analysis module provides a way to measure Astralis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Astralis pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Astralis AS Company EBITDA Analysis

Astralis' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Astralis EBITDA

    
  (7.85 M)  
Most of Astralis' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astralis AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Astralis AS reported earnings before interest,tax, depreciation and amortization of (7.85 Million). This is 100.16% lower than that of the Communication Services sector and significantly lower than that of the Entertainment industry. The ebitda for all United States stocks is 100.2% higher than that of the company.

Astralis EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astralis' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Astralis could also be used in its relative valuation, which is a method of valuing Astralis by comparing valuation metrics of similar companies.
Astralis is currently under evaluation in ebitda category among its peers.

Astralis Fundamentals

About Astralis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Astralis AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astralis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astralis AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Astralis Pink Sheet

If you are still planning to invest in Astralis AS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astralis' history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments